N. Verhoeff

发表

Alzheimer's Disease, Cerebrovascular Disease, and the β-amyloid Cascade

Sandra E Black, S. Black, K. Honjo, 2012, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Theta–gamma coupling and ordering information: a stable brain–behavior relationship across cognitive tasks and clinical conditions

Corinne E. Fischer, B. Pollock, B. Mulsant, 2020, Neuropsychopharmacology.

Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.

N. Verhoeff, E. V. van Royen, O. Kapucu, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pharmacological implications for neuroreceptor imaging

N. Verhoeff, N.P.L.G. Verhoeff, 2004, European Journal of Nuclear Medicine.

Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia

Alan A. Wilson, M. Freedman, B. Pollock, 2011, Neuropsychiatric disease and treatment.

Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open‐label pilot study

Alan A. Wilson, B. Pollock, S. Houle, 2013, International journal of geriatric psychiatry.

Dosimetry of iodine-123 iodobenzamide in healthy volunteers

H. Kung, N. Verhoeff, M. Stabin, 1993, European Journal of Nuclear Medicine.

In vivo characterisation of 3-iodo-6-methoxybenzamide123I in humans

B. Toone, I. Cullum, N. Verhoeff, 2004, European Journal of Nuclear Medicine.

A simple and high‐yield synthesis of (S)‐BZM, (R)‐BZM AND (S)‐IBZM for the preparation of (S)‐123I‐IBZM

H. M. Buck, N. Verhoeff, J. Vekemans, 1990 .

Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease?

K. Honjo, N. Verhoeff, Kie Honjo, 2009, Alzheimer's & Dementia.

Comparison of manual and semi-automated delineation of regions of interest for radioligand PET imaging analysis

Curtis B Caldwell, Joel Ramirez, Sandra Black, 2007, BMC nuclear medicine.

Intracranial dissemination of a macroprolactinoma

N. Verhoeff, D. Bosch, J. Assies, 1993, Clinical endocrinology.

Imaging of dopamine D2 and somatostatin receptors in vivo using single-photon emission tomography in a patient with a TSH/PRL-producing pituitary macroadenoma

F. Bemelman, N. Verhoeff, E. A. Royen, 1993, European Journal of Nuclear Medicine.

Commentary on the letter for Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease?

K. Honjo, N. Verhoeff, Kie Honjo, 2010, Alzheimer's & Dementia.

Amyloid imaging in vivo: implications for Alzheimer's disease management.

N. Verhoeff, 2007, Expert opinion on medical diagnostics.

Dopamine D2–Receptor Imaging With 123I-Iodobenzamide SPECT in Migraine Patients Abusing Ergotamine: Does Ergotamine Cross The Blood Brain Barrier?

M. Ferrari, N. Verhoeff, E. A. Royen, 1993, Cephalalgia : an international journal of headache.

Dosimetry of iodine-123 iomazenil in humans

N. Verhoeff, E. A. Royen, E. Busemann Sokole, 1993, European Journal of Nuclear Medicine.

Quantification of central benzodiazepine receptor binding potential in the brain with 123I-iomazenil SPECT: technical and interobserver variability.

N. Verhoeff, E. V. van Royen, H. Blok, 1993, Nuclear medicine communications.

Abstracts of papers Pharmacological meeting

N. Ramsey, J. M. Ree, M. Danhof, 1985, Pharmaceutisch Weekblad.

Indium-111-DTPA-octreotide uptake measured in normal and abnormal pituitary glands.

A. Miedema, N. Verhoeff, E. V. van Royen, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The Role of Neuroimaging in Development of and Treatment With Antipsychotics

S. Kapur, N. Verhoeff, 2001 .

Basics and Recommendations for Brain SPECT

O. Schober, N. Verhoeff, E. V. van Royen, 1992, Nuklearmedizin.

In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain.

N. Verhoeff, M. Feenstra, K. D. de Bruin, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Focus localization in patients with partial epilepsy with 99Tcm-HMPAO SPECT under continuous surface EEG monitoring.

H. Weinstein, N. Verhoeff, A. Aldenkamp, 1992, Nuclear medicine communications.

Memory complaints, memory disorders and focus localization in patients with partial epilepsy

H. Weinstein, N. Verhoeff, A. Aldenkamp, 1992, Seizure.

Potential for imaging cerebral amyloid deposits using 123I-labelled serum amyloid P component and SPET.

R. Roos, E. Pauwels, N. Verhoeff, 1996, Nuclear medicine communications.